CF breakthrough: could new drugs end daily nose rinses?
NCT ID NCT06996951
Summary
This study aims to find out if adults with cystic fibrosis who are taking newer, highly effective modulator drugs can safely stop their daily nasal treatments like saline rinses, steroid sprays, and antibiotic drops. Researchers will follow 64 patients for 12 weeks, randomly assigning them to either continue or stop their nasal therapies while monitoring sinus health, lung function, and quality of life. The goal is to simplify treatment regimens and reduce medication burden if these extra therapies are no longer needed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS (CF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana University Health
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.